Fervent Pharma Synergies Limited (the company) is a public company
domiciled in India and incorporated under the provisions of the
Companies Act, 1956. Its shares are listed on the Bombay Stock Exchange
The company is engaged in the trading of chemicals, solvents and other
pharmaceutical products. It also lends short term funds as and when
available with the company, for earning business income in line with
continuation of business activities of its amalgamating companies.
The Company has only one class of shares referred to as equity shares
having a par value of Rs.10/-. Each holder of equity shares is entitled
to one vote per share. The Company declares and pays dividends in
Indian rupees.The dividend proposed by the Board of Directors is
subject to the approval of the shareholders in the ensuing Annual
During the year ended March 31, 2012, there was Nil dividend recognized
as distributions to equity shareholders.
In the event of liquidation of the Company,the holders of equity shares
will be entitled to receive any of the remaining assets of the company,
after distribution of all preferential amounts. The distribution will
be in proportion to the number of equity shares held by the
The Company does not have any Holding or subsidiary company and hence
there is no question of any shares of the company being held by its
holding company, ultimate holding company and their
1.1 Since there are no manufacturing activities, the additional
information pursuant to para 3(ii)(a), 4C and 4D of part II of the
Schedule VI of the Companies Act, 1956 is not applicable.
Information relating to Micro and Small Enterprises (MSEs), as
applicable, is generally given in respect of MSEs to the extent they
can be identified on the basis of information available with the
Company and pursuant to amendment of Schedule VI to the Companies Act,
1956 (the Act) vide Notification dated 16th November, 2007 issued by
the Central Government. During the year under review, there is no
reporting required under this clause.
1.2 There is no contingent liability required to be reported.
1.3 Value of Trading Merchandise imported during the year - NIL
1.4 Value of imported stores, spares and components consumed during
the year - NIL
1.5 Expenditure in Foreign Currency Equivalent to - NIL
1.6 CIF value of Imports - NIL
1.7 Remittances during the year in Foreign Currency on account of
Dividend to Non-Resident Shareholders - NIL
1.8 Earnings in Foreign Exchange - NIL
1.9 The Company operates only in a single segment of Business and as
such no separate segment reporting is required.
1.10 Related Parties Disclosure
i. Names of Related Parties and description of relationship
a. Group Associate Companies
Posse Investments Private Limited
Leeverage Finance and Securities Private Limited
Blueplus Securities Private Limited
Yester Investments Private Limited
Hurricane Investments Private Limited
Fervent Securities Private Limited
b. Key Managerial Personnel
Vijay P. Thakkar, Managing Director
Sanjay P. Thakkar, Director
Ashok P. Gohil, Director
c. Relative to key managerial personnel
Urvi Vijay Thakkar (Wife of Vijay P. Thakkar, Managing Director)
Karan Vijay Thakkar (Son of Vijay P. Thakkar, Managing Director)
Bina Sanjay Thakkar (Wife of Sanjay P. Thakkar, Director)
Kunal Sanjay Thakkar (Son of Sanjay P. Thakkar, Director)
Jayshree P. Thakkar (Mother of Vijay P. Thakkar and Sanjay P. Thakkar)
Rekha Ashok Gohil (Wife of Ashok P. Gohil, Director)
Upasna Ashok Gohil (Daughter of Ashok P. Gohil, Director)
1.11 As the Company does not carry on any manufacturing activity,
information regarding Licensed / Registered Capacity, Installed
Capacity is not applicable.
1.12 The figures have been regrouped / rearranged, wherever necessary.
Previous year''s figures are also reclassified in accordance with the
requirements of new schedule VI applicable in the current year.